New-onset diabetes after renal transplantation in a patient with a novel HNF1B mutation
New-onset diabetes after renal transplantation in a patient with a novel HNF1B mutation
复制标题
具有新型 HNF1B 突变的患者肾移植后新发糖尿病
DOI:
10.1111/petr.12690
复制
发表时间:
2016
影响因子:
1.3
通讯作者:
Hattori M.
中科院分区:
文献类型:
--
作者:
Kanda S;Morisada N;Kaneko N;Yabuuchi T;Nawashiro Y;Tada N;Nishiyama K;Miyai T;Sugawara N;Ishizuka K;Chikamoto H;Akioka Y;Iijima K;Hattori M.
CAKUT are the most frequent causes of ESRD in children. Mutations in the gene encodingHNF1B, a transcription factor involved in organ development and maintenance, cause a multisystem disorder that includes CAKUT, diabetes, and liver dysfunction. Here, we describe the case of a patient with renal hypodysplasia who developed NODAT presenting with liver dysfunction. The NODAT was initially thought to be steroid and FK related. However, based on the patient's clinical features, including renal hypodysplasia and recurrent elevations of transaminase, screening for anHNF1Bmutation was performed. Direct sequencing identified a novel splicing mutation ofHNF1B, designated c.344 + 2T>C. Because CAKUT is the leading cause of ESRD in children andHNF1Bmutations can cause both renal hypodysplasia and diabetes,HNF1Bmutations may account for a portion of the cases of NODAT in pediatric patients who have undergone kidney transplantation. NODAT is a serious and major complication of solid organ transplantation and is associated with reduced graft survival. Therefore, for the appropriate management of kidney transplantation, screening forHNF1Bmutations should be considered in pediatric patients with transplants caused by CAKUT who develop NODAT and show extra‐renal symptoms.